Clover Health Investments, Corp. (NASDAQ:CLOV) Q3 2021 Earnings Conference Call November 8, 2021 5:00 PM ET Company Participants Vivek Garipalli – CEO Derrick Nueman – Vice President of Investor Relations Andrew Toy – President and CTO Mark Herbers – CFO Conference Call Participants Kevin Fischbeck – Bank of America Ralph Giacobbe – Citi Jonathan Yong – Credit Suisse Calvin Sternick – JPMorgan Gary Taylor – Cowen Operator Good day, and thank you for standing by. Welcome to the Clover Health's Third Quarter ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________________ FORM 10-Q ________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market LLC 1 For the quarterly period ended September 30, 2021 OR o TRANSITION REPORT PURSUANT TO ...

Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2021 Earnings Conference Call August 11, 2021 5:00 PM ET Company Participants Derrick Nueman - Vice President, Investor Relations Vivek Garipalli - Chief Executive Officer Andrew Toy - President and Chief Technology Officer Joe Wagner - Chief Financial Officer Conference Call Participants Kevin Fischbeck - Bank of America Cal Sternick - JPMorgan Ralph Giacobbe - Citi Operator Good day and thank you for standing by. Welcome to the Clover Health’s Second Quart ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________________ ________________________________________ 1 FORM 10-Q ________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ | --- | |------ ...

Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2021 Earnings Conference Call May 17, 2021 8:30 AM ET Company Participants Derrick Nueman - Head of IR and Corporate Strategy Vivek Garipalli - CEO Andrew Toy - President Joe Wagner - CFO Conference Call Participants Kevin Fischbeck - Bank of America Jailendra Singh - Credit Suisse Lisa Gill - JPMorgan Operator Good day and thank you for standing by. Welcome to the Clover Health's First Quarter 2021 Earnings Call. At this time, all participants are in a list ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market LLC Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 CLOVW The NASDAQ Stock Market LLC FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quart ...

Table of Contents Index to Financial Statements UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-39252 CLOVER HEALTH INVESTMENTS, CORP. (Exact name of registrant as specified in its ...

Clover Health Investments, Corp. (NASDAQ:CLOV) Q4 2020 Earnings Conference Call March 1, 2021 5:00 PM ET Company Participants Vivek Garipalli – Chief Executive Officer Andrew Toy – President and Chief Technology Officer Joe Wagner – Chief Financial Officer Conference Call Participants Kevin Fischbeck – Bank of America Gary Taylor – JPMorgan Ralph Giacobbe – Citi Operator Ladies and gentlemen, thank you for standing by and welcome to the Clover Health Fourth Quarter 2020 Earnings Conference Call. At this tim ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39252 Social Capital Hedosophia Holdings Corp. III (Exact name of registrant as specified in its charter) | --- | --- | |--------- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39252 Social Capital Hedosophia Holdings Corp. III (Exact name of registrant as specified in its charter) | --- | --- | |-------------- ...